Employees Celebrate by Performing 100 Acts of Kindness Throughout the Year
MURRAY HILL, N.J.--(BUSINESS WIRE)--April 12, 2007--C. R. Bard,
Inc. (NYSE-BCR) has announced the 100th anniversary celebration of its
founding with the pledge that its employees around the world will
perform a total of 100 charitable acts throughout the year. A web
site, www.bard100.com, has been launched to provide an overview of the
company's centennial and to track the Acts of Kindness.
Since 1907, Bard has been developing innovative medical
technologies that have become cornerstones of modern healthcare.
Charles Russell Bard, an importer of French silks, founded the company
that bears his name after a bout of urinary discomfort prompted him to
try Gomenol, a medication refined from eucalyptus trees and
manufactured in France. Impressed with the results, he obtained
exclusive U.S. distribution rights to the product, and soon expanded
his offerings to include many other urological products.
Today, C. R. Bard, Inc. is a leading multinational developer,
manufacturer and marketer of innovative, life-enhancing medical
technologies in the fields of vascular, urology, oncology and surgical
specialty products, employing approximately 9,400 people in over 20
countries around the world. Bard has pioneered such devices as the
Foley catheter, the heart-pacing catheter, the arterial prosthesis and
the angioplasty catheter.
"As a leading medical technology company, we've always believed we
should strengthen the wellness of our communities and help improve the
quality of life of people around the world," commented Tim Ring,
Chairman and CEO. "This culture of caring has been a hallmark of our
organization for 100 years, and there's no better way to celebrate our
centennial than by practicing our values."
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill,
N.J., is a leading multinational developer, manufacturer and marketer
of innovative, life-enhancing medical technologies in the fields of
vascular, urology, oncology and surgical specialty products.
CONTACT: C. R. Bard, Inc.
Investor Relations:
Eric J. Shick
Vice President, Investor Relations
908-277-8413
or
Media Relations:
Holly P. Glass
Vice President, Government and Public Relations
703-754-2848
SOURCE: C. R. Bard, Inc.
|
